Published in J Interv Card Electrophysiol on March 01, 2001
Transseptal left heart catheterization. A review of 450 studies and description of an improved technic. Circulation (1962) 3.05
Transseptal left atrial puncture; new technique for the measurement of left atrial pressure in man. Am J Cardiol (1959) 1.66
Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. Eur Heart J (1998) 1.63
Transseptal left heart catheterization for cardiac ablation procedures. J Interv Card Electrophysiol (2001) 1.61
Technique for transseptal catheterization of the left atrium; preliminary report. J Thorac Surg (1959) 1.38
Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1999) 1.31
The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn (1994) 1.26
Transseptal left heart catheterization: experience with a new technique in 520 pediatric and adult patients. Pediatr Cardiol (1984) 1.09
Transseptal left heart catheterization: a review of 278 studies. Clin Cardiol (1986) 1.08
Nonfluoroscopic transseptal catheterization: safety and efficacy of intracardiac echocardiographic guidance. J Cardiovasc Electrophysiol (1998) 1.07
Usefulness of intracardiac echocardiography in complex transseptal catheterization during percutaneous transvenous mitral commissurotomy. Mayo Clin Proc (1996) 0.83
Left atrial and ventricular transseptal catheterization review: losing skills? Cathet Cardiovasc Diagn (1987) 0.82
Echocardiography in the invasive laboratory: utility of two-dimensional echocardiography in performing transseptal catheterization. Mayo Clin Proc (1998) 0.81
Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J Gen Virol (1983) 3.06
Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol (1976) 2.05
Toxoplasma gondii: calcium ionophore A23187-mediated exit of trophozoites from infected murine macrophages. Exp Parasitol (1982) 1.68
Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int J Cardiol (1991) 1.53
Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes. J Immunol (1975) 1.50
Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. Indian Heart J (2009) 1.42
Percutaneous transluminal balloon dilatation in discrete subaortic stenosis. Am Heart J (1988) 1.39
Pictorial CME. Dystrophic myocardial calcification. J Assoc Physicians India (2001) 1.39
Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis. Nature (1980) 1.37
Experience with recycled cardiac pacemakers. Indian Heart J (1992) 1.15
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci (1997) 1.13
Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2. Z Immunitatsforsch Immunobiol (1977) 1.13
[Demonstration of mycoplasma pneumoniae in cerebrospinal fluid in acute polyneuritis]. Dtsch Med Wochenschr (1972) 1.10
Balloon angioplasty for renovascular hypertension in Takayasu's arteritis. Am Heart J (1993) 1.10
Killing of mycoplasmas by the antibodies to foreign antigens acquired by the organisms from the growth medium. Med Microbiol Immunol (1972) 1.08
Massive congenital submitral aneurysm of the left ventricle: a case report. Indian Heart J (1990) 1.06
Search for the presence of lectin-binding sites on Toxoplasma gondii. J Parasitol (1977) 1.06
Immunoblot analysis of the serological response in Hantavirus infections. J Med Virol (1989) 1.05
Cytotoxicity mediated by soluble macrophage product(s). J Natl Cancer Inst (1975) 1.05
Proteolytic activity of Cryptococcus neoformans against human plasma proteins. Med Microbiol Immunol (1972) 1.01
The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells. Eur J Immunol (1980) 1.01
Balloon angioplasty of the aorta in Takayasu's arteritis: initial and long-term results. Am Heart J (1992) 0.96
Neuraminidase activity in Mycoplasma gallisepticum. Infect Immun (1972) 0.96
Mitral regurgitation following percutaneous transvenous mitral commissurotomy: a single-center experience. J Heart Valve Dis (2000) 0.95
Hybridoma-derived monoclonal immunoglobulin M antibodies to Legionella pneumophila serogroup 1 with diagnostic potential. J Clin Microbiol (1983) 0.94
Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome. Immunol Lett (1986) 0.93
Intracellular behaviour of Leishmania enriettii within murine macrophages. Experientia (1978) 0.93
Multiplication of Toxoplasma gondii in enucleated L cells. Nat New Biol (1973) 0.93
A study on the role of complement in the immune inhibition of mycoplasmal growth. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.93
Percutaneous balloon mitral valvuloplasty in children and young adults with rheumatic mitral stenosis. Am Heart J (1989) 0.91
In vitro antilisterial activity of soluble product(s) released from Listeria-immune murine peritoneal macrophages. Infect Immun (1974) 0.90
Hybridomas secreting monoclonal antibody with specificity for Toxoplasma gondii. J Parasitol (1980) 0.90
Evaluation of non-radioactive in situ hybridisation method to detect Chlamydia trachomatis in cell culture. Genitourin Med (1988) 0.90
Experimental sporotrichosis in the normal and modified host. Sabouraudia (1972) 0.89
Congenital aneurysm of the muscular interventricular septum with patent ductus arteriosus. Indian Heart J (1997) 0.89
Atrioventricular valve orifice areas in normal subjects: determination by cross-sectional and Doppler echocardiography. Int J Cardiol (1994) 0.88
[The occurrence of neuraminidase in Mycoplasma gallisepticum]. Med Microbiol Immunol (1972) 0.87
Electron microscope observations on the interaction of Mycoplasma fermentans with Trichomonas vaginalis. Z Parasitenkd (1985) 0.85
Characteristics of soluble T-cell derived factors(s) which can induce non-immune murine macrophages to exert anti-Toxoplasma activity. Z Immunitatsforsch Immunobiol (1978) 0.85
In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells. Z Immunitatsforsch Exp Klin Immunol (1972) 0.85
Immunoelectrophoretic demonstration of proteolytic activity against human proteins by Mycoplasma laidlawii. Z Immunitatsforsch Allerg Klin Immunol (1970) 0.85
Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol (1994) 0.84
Cytochalasin B-induced activation in the synthesis of L-cell virus particles. J Gen Virol (1973) 0.84
Interferon enhances T cell mediated cytotoxicity of H-2 compatible target cells infected with UV-inactivated herpes simplex virus. Arch Virol (1978) 0.84
On the incidence of mycoplasma contamination in cell cultures. Zentralbl Bakteriol Orig A (1972) 0.84
Fatal cerebral edema following angiocardiography: a case report. Int J Cardiol (1985) 0.84
Effects of labetalol on left ventricular mass and function in hypertension--an assessment by serial echocardiography. Int J Cardiol (1984) 0.83
IgG Fc-binding receptors on spermatozoa. Eur J Immunol (1980) 0.83
Coronary artery anomalies in tetralogy of Fallot. Cardiovasc Intervent Radiol (1987) 0.83
Electron microscopy of ultrathin sections of Mycoplasma gallisepticum (strain TT) organisms grown on glass surface. Pathol Microbiol (Basel) (1973) 0.82
Paroxysmal supraventricular tachycardia. Role of His bundle electrography and electrical pacing. Indian Heart J (1981) 0.82
Generation of cytolytic T-cell cultures displaying measles virus specificity and human histocompatibility leukocyte antigen restriction. Infect Immun (1982) 0.82
Attempts to produce experimental intestinal cryptococcosis and sporotrichosis. Mycopathol Mycol Appl (1967) 0.82
Amphotericin B in ocular histoplasmosis of rabbits. Arch Ophthalmol (1966) 0.82
Topographical localization of distinct antigenic domains of Toxoplasma gondii with the aid of monoclonal antibodies. Z Parasitenkd (1984) 0.81
Survival of Cryptococcus neoformans in the gastrointestinal tract of pigeons following ingestion of the organism. J Infect Dis (1968) 0.81
Anaphylactoid reaction to angiographic contrast media: recurrence despite pretreatment with corticosteroids. Cathet Cardiovasc Diagn (1984) 0.81
Fine-needle aspiration diagnosis of carotid body tumor: report of a case and review of experience with cytologic features in four cases. Diagn Cytopathol (1997) 0.81
The nature of host-cell herpes-simplex virus interactions(s) that renders cells susceptible to virus-specific cytotoxic T cells. Immunobiology (1980) 0.81
Balloon angioplasty of native coarctation of the aorta in adolescents and young adults. Am Heart J (1992) 0.81
Pulmonary sporotrichosis in mice following intranasal infection. Am Rev Respir Dis (1966) 0.80
Experimental cutaneous sporotrichosis. Mykosen (1965) 0.80
Establishment of hybridoma cell lines secreting anti-Legionella pneumophila serogroup 1 monoclonal antibodies with immunodiagnostic potential. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.80
Myocardial depressant effect of nitrous oxide after valve surgery. Eur J Anaesthesiol (1994) 0.79
Pulmonary hemodynamic changes after intravariceal sclerotherapy with absolute alcohol. Gastrointest Endosc (1988) 0.79
Direct demonstration and isolation of Legionella pneumophila (serogroup 1) from bathroom water specimens in a hotel. Zentralbl Bakteriol Mikrobiol Hyg B (1983) 0.79
Contribution of macrophage arginase in the intrinsic restriction of herpes simplex virus replication in permissive macrophage cultures induced by gamma-interferon containing products of activated spleen cells. Immunobiology (1983) 0.79
Noncompaction of left ventricular myocardium in the presence of calcific aortic stenosis in an adult. Indian Heart J (2002) 0.79
Experimental cutaneous primary infection with Cryptococcus neoformans (Sanfelice) Vuillemin. Mycopathol Mycol Appl (1965) 0.79
Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells. Br J Cancer (1973) 0.79
Histoplasmosis in India. A critical review. Mycopathol Mycol Appl (1970) 0.79
Production of neutralizing antibody to rabies and vesicular stomatitis viruses by hybrid cell lines. Cell Immunol (1980) 0.79
Induction of virus specific and H-2 restricted cytotoxic T cells by UV inactivated murine cytomegalovirus. Arch Virol (1979) 0.79
Contribution of immune interferon (IFN-gamma) in lymphokine-induced anti-toxoplasma activity: studies with recombinant murine IFN-gamma. Immunobiology (1985) 0.79
Verapamil in idiopathic ventricular tachycardia of right bundle branch block morphology: observations during electrophysiologic and exercise testing. Pacing Clin Electrophysiol (1986) 0.78
In vitro acquisition of resistance against herpes simplex virus by permissive murine macrophages. Arch Virol (1979) 0.78
Salutary effects of intravenous ajmaline in patients with paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways: blockade of the retrograde fast pathway. Circulation (1984) 0.78
Production and characterization of monoclonal antibodies specific for pathogenic serogroups O:3, O:8, and O:9 of Yersinia enterocolitica. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.78
Generation of hybridoma cell lines producing monoclonal antibodies against Toxoplasma gondii or rabies virus following fusion of in vitro-immunized spleen cells with myeloma cells. Ann Immunol (Paris) (1981) 0.78
Enzymatic degradiation of human lipoproteins by mycoplasmas. Experientia (1970) 0.78
Experimental ocular histoplasmosis in pigeons. Am J Ophthalmol (1966) 0.78
Comparison of atrial and VVI pacing modes in symptomatic sinus node dysfunction without associated tachyarrhythmias. Indian Heart J (1991) 0.78
Cross sectional echocardiographic left ventricular ejection fraction: method based variability. Indian Heart J (1992) 0.78
Calcified mobile papillary fibroelastoma of the tricuspid valve: a case report. Indian Heart J (1988) 0.77
Analysis of the roles of immune interferon (IFN-gamma) and colony-stimulating factor(s) in the induction of macrophage anti-toxoplasma activity. Immunobiology (1984) 0.77
Protection of mice from malignant tumor implants by enucleated tumor cells. J Natl Cancer Inst (1974) 0.77
Mycoplasma interactions with cell cultures, uncultured living cells and the problems posed by their presence in tissue cultures. Klin Wochenschr (1972) 0.77
Doppler echocardiographic determination of aortic and pulmonary valve orifice areas in normal adult subjects. Int J Cardiol (1992) 0.77
Comparative evaluation of left ventricular function in sick sinus syndrome on different long-term pacing modes. Indian Heart J (1995) 0.77
Ajmaline-induced torsade de pointes. Cardiology (1985) 0.76
Experimental histoplasmic iridocyclitis in chickens. Arch Pathol (1967) 0.76
CSI/IHRS practice guidelines on follow-up of patients with permanent pacemakers: a Cardiology Society of India/Indian Heart Rhythm Society task force report on practice guidelines on follow-up of patients with permanent pacemakers. Indian Heart J (2012) 0.75
Unique phenotypes of typical and inverted Takotsubo cardiomyopathy in young females. Indian Heart J (2011) 0.75
Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways. Br Heart J (1983) 0.75
Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction. Indian Heart J (2012) 0.75
Maintenance of Fc receptors in hybrid cell lines obtained by fusing mouse splenic macrophages with mouse myeloma cells. Eur J Cell Biol (1979) 0.75